NINLARO
Live / Registered — Registered and renewed (as of 17 Feb 2026)
What this means for you
Registered since 23 Feb 2016. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 23 Feb 2026).
Record
- Serial number
- 85854620
- Registration number
- 4905454
- Mark type
- Stylized text
- Filed
- 20 Feb 2013
- Published for opposition
- 16 Jul 2013
- Registered
- 23 Feb 2016
- Next maintenance due
- 23 Feb 2026
- Attorney of record
- Karl M. Zielaznicki, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use, namely, for the treatment of hematological malignancies and cancer; pharmaceutical preparations for the treatment of cancer
Owner
- Millennium Pharmaceuticals, Inc., Cambridge, MA, US
- Millennium Pharmaceuticals, Inc., Cambridge, MA, US
- Millennium Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 17 Feb 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 17 Feb 2026 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 17 Feb 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 17 Feb 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Nov 2025 — TEAS SECTION 8 & 9 RECEIVED
- 30 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Feb 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 12 Oct 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 12 Oct 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 12 Oct 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Jul 2021 — TEAS SECTION 8 & 15 RECEIVED
- 23 Feb 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 Aug 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED